Wendell Jones, Ph.D. | April 24, 2019

A Pan-Cancer Analysis of the TME Shows Reproducibility but Tissue-Dependent Associations between RNA-based Immune Signatures, Tumor Mutational Burden, and Outcomes

Q2 Solutions | EA Genomics Immune Landscape Signatures
This presentation, presented at the 2019 MAQC Society conference, discusses 3 types of Reproducibility related to RNA-based Immune Signatures in the Tumor MicroEnvironment (TME).

Download presentation to learn more.

Related Services:
Immune Landscape Signatures for Characterization of Tumor Microenvironment and Response to Therapy

Gene expression and analysis for detection of 15 Immune Landscape Signatures

Tumor Mutational Burden (TMB) Assay for Response to Immunotherapy

TMB assay utilizing whole exome sequencing (WES) methodology and proprietary variant analysis compendium

A Pan-cancer View of Immune Cell Activity, Immune Checkpoints, and Tumor Mutational Burden

Aspects of immune cell activity and their pro and anti-tumor characteristics

Long-Term Disease-Free Survival in High Grade Serous Ovarian Cancer (HGSOC) is Dependent on Immune Microenvironment Characteristics of Primary Tumor

Application of RNA-based immune signatures in predicting disease-free survival

Read More